当前位置: 首页 > 期刊 > 《英国医学杂志》 > 2005年第9期
编号:11307290
Legalised euthanasia will violate the rights of vulnerable patients
http://www.100md.com 《英国医学杂志》 2005年第9期
     1 Centre for Bioethics and Philosophy of Medicine, University College London UB1 3HW,2 House of Lords, London SW1A 0PW,3 Association for Palliative Medicine of Great Britain and Ireland, Southampton SO17 1DL

    Doctors in the United Kingdom can accompany their patients every step of the way, up until the last. The law stops them helping their patients take the final step, even if that is the patient's fervent wish. Next month's debate in the House of Lords could begin the process of changing the law. To help doctors decide where they stand we publish a range of opinions
, 百拇医药
    Introduction

    The chameleon of euthanasia continues to change, and the current shade is physician assisted suicide. The politically correct position for clinicians is "studied neutrality" since doctors will not really be involved in assisted suicide. Thus the issue has slipped past the BMA,1 and the recent House of Lords' report on assisted dying suggests that euthanasia and assisted suicide are different.2 This cannot be. What doctor prescribing for assisted suicide would refuse to complete it with euthanasia In the Netherlands just under one in five physician assisted suicides ends in lethal injection.3 Were physician assisted suicide legalised, doctors would have the new duty of therapeutic killing,4 even if they planned only to prescribe lethal medication. Both are killings justified as treatment, hence we use the term therapeutic killing simply because it describes precisely what is done. Medicine cannot escape; quite aside from patient safety, legalising physician assisted suicide will have a profound and ubiquitous effect on clinical codes, duties, and practice.w1-w15
, 百拇医药
    Dutch protests in 2001 as parliament debated legislation and euthanasia

    Credit: SERGE LIGTENBERG/AP/EMPICS

    Change is unjustified

    Autonomy and suffering are the usual justifications for change. The autonomy argument is thin. In all legislatures, the final decision for physician assisted suicide or therapeutic killing rests with the doctor. Patients' perception of total control over this type of death is illusory. Evidence from Oregon shows that patients have to shop around for compliant doctors, and in the Netherlands about a fifth of requests are denied because patients are not suffering enough.5-7
, 百拇医药
    Protecting the vulnerable

    The cardinal argument against legalised euthanasia, however, is the insoluble ethical conflict between meeting individuals' demands for therapeutic death and ensuring that incapable, vulnerable, or voiceless patients will not have lethal treatment prescribed as their best interest. Coercion is a real, immeasurable risk. As with cardiopulmonary resuscitation, clinicians will have to discuss the potential for assisted suicide with all dying patients. Arguably this promotes freedom, trust, and openness, yet, as disabled people find with discussions about resuscitation, it could also infer a duty to die.8 9 Requests for physician assisted suicide because of "being a burden" have risen in Oregon from 1:5 to 1:3 since its Death with Dignity Act was implemented.10
, 百拇医药
    Treatments are medical goods. Since justice dictates that rights to appropriate treatment are universal, if assisted suicide is legal it becomes an optional treatment, not just for patients who want it but also for those who need it. A moral obligation exists for death to be a legitimate interest for all our patients. Therefore, assisted suicide or therapeutic killing becomes our proper duty towards anyone claiming or appearing to suffer unbearably, regardless of prognosis or capacity to consent. The inevitable accommodation of this shift in the status of assisted suicide and therapeutic killing is seen clearly in the Netherlands. Therapeutic killing is now extended to children,11 12 people with psychiatric illness,13 14 and those who are mentally incapable.15 Therapeutic killing without consent has become laudable and morally necessary.16 17 The Netherlands now plans a committee to decide on such cases nationally.18 Even UK protagonists recognise that safeguards are limited and expect legislation to be incremental.2 Yet therapeutic killing without explicit request, or of those lacking capacity, is the ultimate violation of autonomy. Although the principle of autonomy is extended for requesting individuals, this is at the expense of others' freedoms.
, http://www.100md.com
    Such collateral damage from the entitlement to therapeutic killing is inescapable. Dutch legislation has failed to improve reporting beyond 54% of all cases or to limit therapeutic killing without consent,16 19 which consistently accounts for about 1 in 7 of reported cases.16 Experience is similar in Belgium.20 Oregon does not police its deaths. The size of this problem is unknowable, and the argument that this promotes autonomy in the sick population as a whole is misleading and unsustainable. Extrapolating the current Dutch figures to the United Kingdom suggests that at steady state, 13 000 deaths may result each year, with around 2000 occurring without request or consent.2
, 百拇医药
    Moral consequences

    In short, any safeguards have no ethical basis once any form of assisted suicide or therapeutic killing is sanctioned. The real question, therefore, is whether we are happy with the moral cost to society and loss of life among vulnerable patients as a result of reclassifying the freedom to die to the right to be killed.

    Naturally, once promoted to a medical good, therapeutic killing becomes a legitimate consideration in resource management. In the first Dutch report in 1990, only one case was cited of a dying patient who was killed to free the bed,21 whereas in the latest survey, 15% of doctors were concerned about economic pressures.16 The nursing literature records similar experience.22
, 百拇医药
    Achieving a good death

    Finally, suffering is extremely complex, part of our humanity, and not exclusive to people who are dying. Paradoxically, as disease overwhelms the dying person, the challenge is not how to be killed, but how either to hang on, or to let go, of life. Suffering can be mitigated but it requires the highly specialised skills and perseverance of a multidisciplinary team and goes well beyond controlling symptoms with drugs.23
, 百拇医药
    Although the presence of specialist palliative care is no argument against therapeutic killing, its absence certainly is, and lack of even basic, consistent provision across the UK is clear.24 An average general practitioner cares for fewer than five dying patients a year; educational programmes consistently find general practitioners and hospital consultants are poor at controlling symptoms and relieving suffering, and many still believe that opioids and sedatives hasten death.25 26 It is unsurprising, then, that many clinicians have seen suffering patients who they have been unable to help. Many doctors assume that they already kill frequently with analgesia or sedation when they do nothing of the sort.
, 百拇医药
    On a balance of harms, legalising physician assisted suicide or therapeutic killing is a far greater risk than compassion for the small minority pleading to be killed might imply. In detailed evidence to the Select Committee the implications for individual doctors in the UK was glossed.2 Every doctor caring for patients will be asked at some stage to assist suicide or kill therapeutically. Before another bill is laid before parliament every doctor must think through all the moral and practical implications for their own practice, for all the others in their clinical team, and, of course, for other patients in their care. Promoting autonomy for all is to help people understand that they can let go and to learn the skills to assist them to do that.23
, 百拇医药
    Summary points

    Any legislation will leave vulnerable groups open to therapeutic killing without consent

    Since this is the ultimate violation of autonomy assisted suicide cannot be separated from euthanasia

    Arguments that legalised euthanasia promotes autonomy do not stand

    Doctors need to consider carefully the full implications of legalisation
, 百拇医药
    References w1-w15 are on bmj.com

    Competing interests: RJDG and DJ gave oral evidence to the Select Committee on the Assisted Dying for the Terminally Ill Bill on behalf of the Association for Palliative Medicine. IGF was a member of that committee.

    Contributors and sources: The authors are among the national leaders in specialist palliative care, practising clinicians, and have researched, taught, and published widely in the discipline. IGF is also professor of palliative medicine, School of Medicine, Cardiff University. This article arose from discussions to distil the issues that emerged from a systematic literature review by RJDG of euthanasia and assisted suicide. RJDG is the guarantor.
, 百拇医药
    References

    British Medical Association. Assisted dying. www.bma.org.uk/ap.nsf/Content/EndoflifeissuesOpenDocument &Highlight=2,Annual,Representatives,Meeting,2005 (accessed 31 Aug 2005).

    House of Lords Select Committee on the Assisted Dying for the Terminally Ill Bill. Report [HL Paper 86-I]. London: Stationery Office, 2005.

    Groenewoud JH, van der Heide A, Onwuteaka-Philipsen BD, Willems DL, van der Maas PJ, van der Wal G. Clinical problems with the performance of euthanasia and physician-assisted suicide in the Netherlands. N Engl J Med 2000;342: 551-6.
, http://www.100md.com
    British Medical Association, General Medical Council. Oral evidence to the select committee on the assisted dying for the terminally ill bill [HL] Vol II Evidence. London: Stationery Office, 2005: 125-6.

    Ganzini L, Nelson HD, Lee MA, Kraemer DF, Schmidt TA, Delorit MA. Oregon physicians' attitudes about and experiences with end-of-life care since passage of the Oregon death with dignity act. JAMA 2001;285: 2363-9.

    Ganzini L, Nelson HD, Schmidt TA, Kraemer DF, Delorit MA, Lee MA. Physicians' experiences with the Oregon death with dignity act. N Engl J Med 2000;342: 557-63.
, http://www.100md.com
    Haverkate I, Onwuteaka-Philipsen BD, van der Heide A, Kostense PJ, van der Wal G, van der Maas PJ. Refused and granted requests for euthanasia and assisted suicide in the Netherlands: interview study with structured questionnaire. BMJ 2000;321: 865-6.

    Campbell J. A right to die I'm more concerned that everyone has the right to live. Times 2004 Dec 2.

    Templeton S-K. Better for old to kill themselves than be a burden, says Warnock. Times 2004 Dec 12.
, 百拇医药
    Oregon Department of Human Services. Fifth annual report on Oregon's death with dignity act. http://egov.oregon.gov/DHS/ph/pas/docs/year5.pdf.

    Leenen JI, Ciesielski-Carlucci C. Force majeure (legal necessity). Justification for active termination of life in the case of severely handicapped newborns after forgoing treatment. Camb Q Healthc Ethics 1993;2: 271-4.

    Van Thiel GJ, van Delden JJ, de Haan K, Huibers AK. Retrospective study of doctors' "end of life decisions" in caring for mentally handicapped people in institutions in the Netherlands. BMJ 1997;315: 88-91.
, http://www.100md.com
    Jochemsen H. Dutch court decisions on nonvoluntary euthanasia critically reviewed. Issues Law Med 1998;13: 447-58.

    Sheldon T. Dutch GP cleared after helping to end man's "hopeless existence". BMJ 2000;321: 1174.

    Sheldon T. Euthanasia endorsed in Dutch patient with dementia. BMJ 1999;319: 75.

    Onwuteaka-Philipsen BD, van der Heide A, Koper D, Keij-Deerenberg I, Rietjens JA, Rurup ML, et al. Euthanasia and other end-of-life decisions in the Netherlands in 1990, 1995, and 2001. Lancet 2003;362: 395-9.
, 百拇医药
    Sheldon T. Dutch GP found guilty of murder faces no penalty. BMJ 2001;322: 509.

    Sterling T. Netherlands hospital euthanizes babies. http://aplancasteronline.com/4/netherlands_child_euthanasia (accessed 15 Sep 2005).

    Jochemsen H, Keown J. Voluntary euthanasia under control Further empirical evidence from the Netherlands. J Med Ethics 1999;25: 16-21.

    Deliens L, Mortier F, Bilsen J, Cosyns M, Vander SR, Vanoverloop J, et al. End-of-life decisions in medical practice in Flanders, Belgium: a nation-wide survey. Lancet 2000;356: 1806-11.
, 百拇医药
    Dutch Department of Health. The Remelink report. The Hague: DoH, 1990.

    Hendin H. The Dutch experience. Issues Law Med 2002;17: 223-46.

    George RJD, Martin J. Non-physical pain: suffering in action. In: Hoy A, Finlay I, Miles A, eds. The effective prevention and control of symptoms in cancer. London: Aesculapius Medical Press, 2004: 107-26.

    House of Commons Health Select Committee. Palliative care fourth report session 2003-4. HC 454-I. London: Stationery Office, 2004.

    Sykes N, Thorns A. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med 2003;163: 341-4.

    Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision making. Lancet 2000;356: 398-9., 百拇医药(R J D George, I G Finlay,)